| Amplitude Energy Limited (AEL) ORDINARY FULLY PAID |
Energy |
$486 |
Investor presentation
|
22 Jul 2026 8:25AM |
$1.535 |
$1.620 |
risen by
5.54%
|
|
| Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID |
Health Care |
$162 |
Optiscan Signs New Research Agreement for Breast Study
|
22 Jul 2026 8:25AM |
$0.140 |
$0.155 |
risen by
10.71%
|
|
OIL - Price-sensitive ASX Announcement
Full Release
Key Points
- Optiscan Imaging Ltd has signed a new Research Agreement with Mayo Clinic for a US breast cancer imaging study.
- The study will evaluate Optiscan's InVueâ„¢ for in vivo surgical imaging and InFormâ„¢ for ex vivo digital pathology imaging.
- 35 US patients undergoing breast-conserving surgery will be recruited for the study.
- The study aims to generate clinical evidence for FDA 510(k) submissions and support the development of AI for breast cancer tissue assessment.
- InVueâ„¢ and InFormâ„¢ devices will be assessed for their utility in surgical-pathology workflow integration.
- The collaboration aims to advance precision-guided breast cancer surgery and enhance clinical expansion.
- The study could support Optiscan’s strategy of building a connected digital ecosystem for cancer surgery and pathology assessment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wesfarmers Limited (WES) ORDINARY FULLY PAID |
Consumer Discretionary |
$90,130 |
Mt Holland lithium expansion - final investment decision
|
22 Jul 2026 8:25AM |
$91.840 |
$79.440 |
fallen by
13.50%
|
|
| Aruma Resources Limited (AAJ) ORDINARY FULLY PAID |
Materials |
$5 |
Aruma Commences Phase 2 of Drilling at Tillex Copper Project
|
22 Jul 2026 8:25AM |
$0.008 |
$0.006 |
fallen by
25%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$3,142 |
Net Tangible Asset Backing
|
22 Jul 2026 8:25AM |
$4.260 |
$4.950 |
risen by
16.20%
|
|
| Mitchell Services Limited (MSV) ORDINARY FULLY PAID |
Materials |
$106 |
Quarterly Investor Update
|
22 Jul 2026 8:25AM |
$0.525 |
$0.500 |
fallen by
4.76%
|
|
MSV - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly revenue of $56.5 million, up 12% from FY25 Q4.
- Quarterly EBITDA of $10.2 million, a 32% increase compared to FY25 Q4.
- Full-year FY26 EBITDA increased by 67% to $42.8 million.
- FY26 earnings before tax reached $20.8 million, up from $0.7 million in FY25.
- Net cash position of $3.5 million as of 30 June 2026.
- Gold contributed 61% and coal 30% to the FY26 revenue.
- Operating rig count increased to 65 by the end of FY26.
- Expected further increase in rig count in FY27.
- Progress in Loop Decarbonisation business.
- Plan to issue fully franked dividends to shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nutritional Growth Solutions Ltd (NGS) ORDINARY FULLY PAID |
Consumer Staple |
$8 |
Proposed issue of securities - NGS
|
22 Jul 2026 8:25AM |
$0.020 |
$0.025 |
risen by
25%
|
|
| Champion Iron Limited (CIA) ORDINARY FULLY PAID |
Materials |
$1,966 |
Change in substantial holding
|
22 Jul 2026 8:24AM |
$3.870 |
$3.510 |
fallen by
9.30%
|
|
| Tetratherix Limited (TTX) ORDINARY FULLY PAID |
Health Care |
$211 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
22 Jul 2026 8:24AM |
$6.750 |
$7.150 |
risen by
5.93%
|
|
TTX - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong cash position of AUD 34.4 million as of June 30, 2026
- Successful capital raise and license revenue support financial position
- Significant advancements in Tetramatrixâ„¢ platform for nasal drug delivery
- New peptide-polymer patents obtained to strengthen IP
- Advanced manufacturing facility under construction in New South Wales
- FDA preparations for Tegenix and TegenEOS products
- New ERP system implemented for operational efficiencies
- Key financial inflows include a $15 million placement and a $4.2 million licence fee
- Preparation for US market entry with Tetramatrixâ„¢ platform
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,412 |
Update - Notification of buy-back - FLT
|
22 Jul 2026 8:24AM |
$11.750 |
$11.780 |
risen by
0.26%
|
|
| Rox Resources Limited (RXL) ORDINARY FULLY PAID |
Materials |
$822 |
Change in substantial holding
|
22 Jul 2026 8:24AM |
$0.385 |
$0.590 |
risen by
53.25%
|
|
| Megado Minerals Limited (MEG) ORDINARY FULLY PAID |
Materials |
$12 |
Corporate presentation - July 2026
|
22 Jul 2026 8:24AM |
$0.017 |
$0.017 |
fallen by
0%
|
|
| Webjet Group Limited (WJL) ORDINARY FULLY PAID |
Consumer Discretionary |
$141 |
Update - Notification of buy-back - WJL
|
22 Jul 2026 8:24AM |
$0.400 |
$0.360 |
fallen by
10%
|
|
| Nordic Resources Limited (NNL) ORDINARY FULLY PAID |
Materials |
$78 |
Strong Drill Results from Wide Step Out Drilling at Kopsa
|
22 Jul 2026 8:24AM |
$0.170 |
$0.205 |
risen by
20.59%
|
|
NNL - Price-sensitive ASX Announcement
Full Release
Key Points
- The results are from Q2 2026 drill program at the Kopsa project.
- Three final holes, totaling 1,223m, were drilled in the southwestern zone at Kopsa.
- Significant mineralisation was discovered in step-out drilling, likely impacting Kopsa's ultimate size.
- Drilling exhibited strong, semi-continuous mineralisation over 100m.
- Results showed excellent continuity with previous drilling.
- The company is well-funded with over A$10M at bank as of March 2026.
- Resource updates are planned post-metallurgical program results.
- The drilling results from 2025 and 2026 have yet to be incorporated into an updated resource for Kopsa.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Block, Inc. (XYZ) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
$4,408 |
Notice of Proposed Sale of Securities
|
22 Jul 2026 8:24AM |
$113.830 |
$116.170 |
risen by
2.06%
|
|
| Charter Hall Long Wale REIT (CLW) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$2,528 |
Becoming a substantial holder
|
22 Jul 2026 8:23AM |
$3.700 |
$3.500 |
fallen by
5.41%
|
|
| Ardea Resources Limited (ARL) ORDINARY FULLY PAID |
Materials |
$103 |
July 2026 Noosa Mining Conference Presentation
|
22 Jul 2026 8:23AM |
$0.405 |
$0.470 |
risen by
16.05%
|
|
ARL - Price-sensitive ASX Announcement
Full Release
Key Points
- Ardea Resources Limited focuses on the Kalgoorlie Nickel Project (KNP), highlighting the Goongarrie Hub as a major asset.
- The Goongarrie Hub is part of a joint venture with a Japanese consortium, which funds the Definitive Feasibility Study (DFS) with a budget of A$98.5 million.
- Ardea Resources holds a 65% interest in the Goongarrie Hub, which is a critical component of their nickel and cobalt resources.
- The company's mineral resources are based on a 0.5% nickel cut-off grade, with several deposits having significant nickel and cobalt content.
- The Noosa Mining Conference Presentation emphasizes the strategic importance of the project in supplying critical minerals.
- Ardea has a strong leadership team with extensive experience in mining, project development, and strategic partnerships.
- The company has a tight capital structure with significant shareholding among the top 40 shareholders.
- Ardea's market capitalization is $92.2 million with a share price of $0.42 as of July 2026.
- The project aims for long-term competitiveness with multi-commodity exploration potential.
- Ardea's strategic partnerships provide technical capability and market access, particularly in the battery and critical minerals supply chains.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brookside Energy Limited (BRK) ORDINARY FULLY PAID |
Energy |
$38 |
Sabres Well Advances into Lateral Section
|
22 Jul 2026 8:23AM |
$0.410 |
$0.400 |
fallen by
2.44%
|
|
BRK - Price-sensitive ASX Announcement
Full Release
Key Points
- Brookside Energy Limited updates on Sabres well in Anadarko Basin.
- Intermediate casing set and curve landed in Sycamore Formation.
- Sabres well is first in two-well Suttles pad development program.
- Brookside holds 70% working interest in the wells.
- Focus on reaching target depth and moving to Whalers well.
- Strategic emphasis on disciplined development and shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$3,065 |
Ceasing to be a substantial holder
|
22 Jul 2026 8:23AM |
$2.320 |
$2.360 |
risen by
1.72%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,833 |
Appendix 3C
|
22 Jul 2026 8:23AM |
$45.730 |
$48.740 |
risen by
6.58%
|
|
| DroneShield Limited (DRO) ORDINARY FULLY PAID |
Industrials |
$1,633 |
Becoming a substantial holder
|
22 Jul 2026 8:23AM |
$2.170 |
$1.765 |
fallen by
18.66%
|
|
| Energy Transition Minerals Ltd (ETM) ORDINARY FULLY PAID |
Materials |
$112 |
Investor Presentation
|
22 Jul 2026 8:23AM |
$0.045 |
$0.051 |
risen by
13.33%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,833 |
Appendix 3C
|
22 Jul 2026 8:23AM |
$45.730 |
$48.740 |
risen by
6.58%
|
|
| Battery Age Minerals Ltd (BM8) ORDINARY FULLY PAID |
Materials |
$11 |
BM8 Expands District-Scale Tenure at Falcon Lake
|
22 Jul 2026 8:23AM |
$0.042 |
$0.049 |
risen by
16.67%
|
|
BM8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Battery Age Minerals Ltd expands landholding at Falcon Lake Project.
- Additional 46 mineral claims staked, increasing total to 60 km².
- Located in Caribou Lake–O'Sullivan Greenstone Belt, Ontario, Canada.
- High-grade lithium drilling results bolster expansion.
- Multi-element potential includes rubidium, caesium, tantalum, and gallium.
- Upcoming prospecting and sampling program planned for late summer/early fall 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$43 |
RAD Announces Positive Phase 2b Trial Results of RAD 101
|
22 Jul 2026 8:22AM |
$0.019 |
$0.010 |
fallen by
47.37%
|
|
RAD - Price-sensitive ASX Announcement
Full Release
Key Points
- 93% concordance between RAD101 PET imaging and MRI.
- Achieved primary endpoint in Phase 2b trial.
- Preliminary 86% sensitivity in 14 patients.
- Plan to advance to U.S. Phase 3 pivotal trial in Q4 2026.
- Imaging market for brain metastases is over $600 million.
- RAD101 has FDA Fast Track Designation.
- Partnership with Siemens Healthineers for Phase 3 trial support.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.